Compare SKE & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKE | MMED |
|---|---|---|
| Founded | 1979 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2017 | 2026 |
| Metric | SKE | MMED |
|---|---|---|
| Price | $31.16 | $11.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $22.56 |
| AVG Volume (30 Days) | 555.7K | ★ 694.7K |
| Earning Date | 05-12-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $37,573.35 | $10.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.40 | $11.45 |
| 52 Week High | $38.77 | $17.86 |
| Indicator | SKE | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 31.12 |
| Support Level | $30.44 | N/A |
| Resistance Level | $34.96 | $15.80 |
| Average True Range (ATR) | 1.24 | 0.69 |
| MACD | -0.06 | -0.09 |
| Stochastic Oscillator | 43.46 | 3.93 |
Skeena Resources Ltd is a mining company in development stage focusing on the construction and development of the Eskay Creek project in British Columbia. Eskay Creek is the next global gold development project and represents one of the highest-grade and lowest-cost open-pit precious metals mines, with substantial silver by-product production.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.